GYRE
Gyre Therapeutics Inc.
7.00$
-0.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +142.5% | -114.1% | – | |
| – | +33.9% | -17.2% | -55.5% | -13.9% | -2.0% | -5.5% | +110.1% | +289.3% | -1.3% | +42.5% | +56.2% | |
| – | -90.6% | +94.8% | +35.9% | +202.0% | +22.9% | +13.2% | -6.1% | +292.5% | -45.5% | -88.6% | +761.3% | |
| – | – | – | -32.2% | -341.4% | – | -131.3% | – | -1,714.3% | – | -310.4% | – | |
| – | +6,700.0% | +72.1% | -95.1% | +1,534.8% | -83.0% | +317.2% | +214.2% | +495.7% | +71.8% | -63.6% | -62.0% | |
| – | +10.3% | -103.5% | +760.2% | +533.9% | – | -64.7% | +398.7% | -128.7% | +43.0% | +0.6% | -97.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -93.0% | – | – | – | |
| – | +86.0% | -89.8% | +3,634.2% | +214.5% | -99.7% | +18,363.6% | -17.9% | -190.8% | – | -15.9% | +1,059.8% | |
| – | +1,316.6% | -168.4% | – | +172.3% | -238.7% | – | -6.7% | -135.9% | – | -360.3% | – | |
| – | – | – | – | – | – | – | – | – | +204.7% | -139.1% | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.